Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Risk-Stratified Therapy for Acute Myeloid Leukemia in Down Syndrome

NCT02521493 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT02521493
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02521493 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Risk-Stratified Therapy for Acute Myeloid Leukemia in Down Syndrome
Lead sponsor
Children's Oncology Group
Phase
Phase 3
Overall status
Active, not recruiting
Start date
December 23, 2015
Completion date
June 30, 2027
Enrollment
280 (actual)
Sites
191

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia, down syndrome, myelodysplastic syndrome, myeloid leukemia associated with down syndrome, myeloproliferative neoplasm